The National Institute on Aging awarded a Project Grant (CFDA 93.866 - Aging Research) in the amount of $2,373,964 to Weill Medical College of Cornell University on September 1, 2024. The award will support a multi-year research project examining the use of telehealth services for long-stay nursing home residents with Alzheimer's disease and related dementias (ADRD). The key objectives are to: 1) Conduct qualitative interviews to understand the facilitators, barriers, and decision-making...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,588,040 to Wake Forest University Health Sciences to examine the use of home-based medical care (HBMC) and telemedicine among people living with Alzheimer's disease and related dementias (PLWD) in both public (Medicare fee-for-service) and private (Medicare Advantage) plans. The study aims to evaluate the impact of HBMC and telemedicine on outcomes such as treatment for ADRD,...
The Department of Health and Human Services' National Institute on Aging provided $2,340,878 under its Aging Research program (CFDA 93.866) to assess the long-term impact of expanded telemedicine use on dementia care. The Regents of the University of California, San Francisco will conduct a sequential mixed-methods study from 2022-2025 to characterize dementia patients' telemedicine use in Kaiser Permanente Northern California and UCSF Health primary care settings. The study will analyze...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a study to examine the impact of telehealth use on the quality of end-of-life care for nursing home residents with Alzheimer's disease and related dementias. The $858,870 award, with a start date of September 15, 2024 and an ultimate completion date of May 31, 2028, will allow the researchers to: Characterize patterns of telehealth provision at the end-of-life for this patient population,...
The University of Rochester received a $1,092,079 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) to study the impacts of informal family caregiving on nursing home residents with Alzheimer's disease and related dementias (ADRD), as well as the associations between state Essential Caregiver (EC) programs and caregiving outcomes during the COVID-19 pandemic. The project aims to determine how family caregiving affects the health of nursing home residents...
This Project Grant award, provided by the National Institutes of Health's National Institute on Aging (CFDA 93.866 - Aging Research), supports a study on the impact of Medicare coverage choice on healthcare utilization and intergenerational transfers among Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The $1,846,173 award, spanning from August 2024 to April 2029, aims to investigate whether ADRD patients in Medicare Advantage (MA) plans experience more preventable...
This $1,933,556 Project Grant awarded by the National Institute on Aging (NIA) under its Aging Research program (CFDA 93.866) will support research to assess the impact of hospital-based health information technology (hospital-HIT) on healthcare quality and equity for patients with Alzheimer's disease and related dementias (ADRD). The primary awardee, the University of Maryland, College Park, will conduct a ten-year longitudinal study to evaluate how hospital-HIT systems that promote care...
The National Institute on Aging (NIA) awarded a $608,731 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Brown University. The 5-year project, beginning on September 1, 2024, will leverage Medicare claims and clinical assessment data to investigate how Medicare and Medicaid financing policies impact post-acute and long-term care utilization and health outcomes for persons living with Alzheimer's disease and related dementias (ADRD). Key research aims include...
This $243,000 Project Grant awarded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) will fund a 5-year study focused on deprescribing potentially inappropriate medications (PIMs) for older adults with Alzheimer's disease and related dementias (ADRD) receiving home health care services. The key objectives are to: 1) Identify factors, barriers, and facilitators associated with routine PIM deprescribing for ADRD patients in home health care through a mixed...
This $3,732,394 five-year Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a cluster randomized trial to evaluate the effectiveness of the Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP) intervention. The study will be conducted by the University of South Florida and will examine its impact on increasing documentation of advance care planning discussions and hospice use among residents with...
The University of Rochester was awarded a $2,247,334 federal Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866). The grant period runs from September 16, 2024 to May 31, 2028. The objective of this study is to use a mixed-method approach to understand multi-level factors at the assisted living (AL), market, and state levels that may influence the impact of the Centers for Medicare & Medicaid Services' (CMS) telemedicine policy on AL residents with Alzheimer's disease and related dementias (ADRD). The study will examine telemedicine and in-person outpatient service utilization, as well as the use of other health services like hospitalizations and long-term nursing home placement. The research aims to provide insights into the potential benefits and challenges of telemedicine use in ALs for residents with ADRD, and to shed light on regulatory policies that may create barriers and disparities in care for this population.